Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?
- PMID: 33073041
- PMCID: PMC7530322
- DOI: 10.21037/tgh.2019.12.09
Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong.Transl Gastroenterol Hepatol. 2019 Jul 11;4:52. doi: 10.21037/tgh.2019.06.07. eCollection 2019. Transl Gastroenterol Hepatol. 2019. PMID: 31463411 Free PMC article.
References
-
- Toro A, Ardiri A, Mannino M, et al. Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study. BMC Surg 2014;14:40. 10.1186/1471-2482-14-40 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources